Home › Compare › GFNCP vs ABBV
GFNCP yields 69.56% · ABBV yields 3.06%● Live data
📍 GFNCP pulled ahead of the other in Year 1
Combined, GFNCP + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GFNCP + ABBV for your $10,000?
General Finance Corporation, a specialty rental services company, provides portable storage, modular space, and liquid containment solutions in North America and the Asia-Pacific regions. The company's portable storage products include storage containers for classroom equipment storage, construction equipment and tool storage, disaster shelters, landscaping sheds, recreational equipment storage, and retail inventory storage applications; and freight containers used in freight transportation. Its modular space products comprise office or portable building containers, ground level offices, and modular buildings and offices for use in general administrative office spaces, military installations, workforce living accommodations, bank branches, classrooms/education, construction offices, day-care facilities, dormitories, general administrative office space, healthcare and rental facilities, retail space, and shelters. The company's liquid containment products consist of portable liquid storage tanks for well-site liquid containment needs, expansion/upgrade projects, highway construction/groundwater sewage, infrastructure projects, major industrial projects, mining pit pump works, municipal sewer and water projects, non-residential construction projects, pipeline construction and maintenance, and refinery turnarounds. It also provides steps, ramps, furniture, portable toilets, security systems, shelving, mud pumps, hoses, splitter valves, tee connectors, and other items used in connection with leased equipment. In addition, the company offers temporary prison holding cells, hoarding units, blast-resistant units, workforce living accommodations, temporary retail frontage units, and observatory units customized from storage containers, as well as shipping container modifications, specialty trailers and tanks, chassis, storm shelters, and trash hoppers. The company was founded in 2005 and is headquartered in Pasadena, California.
Full GFNCP Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.